Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Total Liabilities (2016 - 2025)

Firefly Neuroscience has reported Total Liabilities over the past 15 years, most recently at $2.8 million for Q4 2025.

  • Quarterly results put Total Liabilities at $2.8 million for Q4 2025, down 42.93% from a year ago — trailing twelve months through Dec 2025 was $2.8 million (down 42.93% YoY), and the annual figure for FY2025 was $2.8 million, down 42.93%.
  • Total Liabilities for Q4 2025 was $2.8 million at Firefly Neuroscience, up from $2.8 million in the prior quarter.
  • Over the last five years, Total Liabilities for AIFF hit a ceiling of $7.2 million in Q1 2025 and a floor of $1.9 million in Q2 2024.
  • Median Total Liabilities over the past 5 years was $3.7 million (2021), compared with a mean of $3.8 million.
  • Biggest five-year swings in Total Liabilities: tumbled 58.2% in 2024 and later soared 249.09% in 2025.
  • Firefly Neuroscience's Total Liabilities stood at $5.9 million in 2021, then dropped by 28.21% to $4.3 million in 2022, then tumbled by 40.44% to $2.5 million in 2023, then surged by 96.52% to $5.0 million in 2024, then tumbled by 42.93% to $2.8 million in 2025.
  • The last three reported values for Total Liabilities were $2.8 million (Q4 2025), $2.8 million (Q3 2025), and $2.8 million (Q2 2025) per Business Quant data.